ArticleEJHaem2026
Effect of Early Administration of Anti-MRSA Drugs for Febrile Neutropenia in Allogeneic Hematopoietic Cell Transplantation.
Article in EJHaem, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: In febrile neutropenia (FN), the empirical use of anti-methicillin-resistant Objectives: To assess the impact of early administration of anti-MRSA drugs on the resolution of fever in patients undergoing allo-HCT. Methods: We retrospectively analyzed 186 allo-HCT patients. Patients receiving anti-MRSA drugs within 3 days of fever onset formed the early-decision group; those treated on or after Day 4 or untreated formed the late-decision group. Results: The early group showed a significantly shorter fever duration than the late group. ( Conclusions: Associations were observed between the timing of anti-MRSA drug administration and clinical outcomes in allo-HCT, including fever resolution and the incidence of aGVHD in older patients. Trial registration: The authors have confirmed clinical trial registration is not needed for this submission.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.